1225014-05-0
Chemical Structure
GLR-19
- CAS No.: 1225014-05-0
- Formula:C102H194N40O20
- Molecular Weight:2300.89
SMILES: O=C(N[C@@H](CC(C)C)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CC(C)C)C(N[C@@H](CC(C)C)C(NCC(N[C@@H](CCCNC(N)=N)C(N[C@@H](CC(C)C)C(N[C@@H](CC(C)C)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CC(C)C)C(NCC(N[C@@H](CCCNC(N)=N)C(N[C@@H](CC(C)C)C(N[C@@H](CC(C)C)C(N[C@@H](CC(C)C)C(N[C@@H](CCCNC(N)=N)C(O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)CN
Biological Activity: GLR-19 is an anti-HIV peptide. GLR-19 also has antiviral activity against HSV-2[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
GLR-19 | GLR-19 is an anti-HIV peptide. GLR-19 also has antiviral activity against HSV-2. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
- [1]. Mishra B, et al. The Importance of Amino Acid Composition in Natural AMPs: An Evolutional, Structural, and Functional Perspective. Front Immunol. 2012 Jul 31;3:221. [Content Brief]
- [2]. Guangshun Wang, et al. De Novo Design of Antiviral and Antibacterial Peptides with Varying Loop Structures. Journal of AIDS & Clinical Research. 2011, S2
Keywords